Free Trial

Henry Schein Q4 EPS Estimate Increased by Leerink Partnrs

Henry Schein logo with Medical background

Key Points

  • Henry Schein, Inc. has had its Q4 2025 earnings per share estimates raised by Leerink Partners to $1.30, increasing from a previous estimate of $1.22.
  • The company reported Q2 earnings of $1.10 per share, falling short of analysts' estimates by $0.09, despite a revenue of $3.24 billion, which exceeded expectations.
  • Multiple analysts have downgraded Henry Schein's stock ratings, with most maintaining a rating of "Hold" and an average price target of $75.58.
  • Want stock alerts on Henry Schein? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Stock analysts at Leerink Partnrs lifted their Q4 2025 EPS estimates for Henry Schein in a research note issued to investors on Tuesday, August 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $1.30 per share for the quarter, up from their previous forecast of $1.22. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's FY2026 earnings at $5.25 EPS, FY2027 earnings at $5.74 EPS and FY2028 earnings at $6.27 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the previous year, the firm posted $1.23 EPS. Henry Schein's revenue for the quarter was up 3.3% on a year-over-year basis.

Other equities research analysts also recently issued reports about the company. Robert W. Baird reiterated a "neutral" rating and issued a $72.00 price target (down from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Evercore ISI decreased their price objective on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a report on Wednesday. Baird R W downgraded shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Finally, Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday, July 14th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $75.58.

Read Our Latest Analysis on Henry Schein

Henry Schein Stock Up 0.1%

Henry Schein stock traded up $0.04 during midday trading on Friday, hitting $65.94. The stock had a trading volume of 1,931,964 shares, compared to its average volume of 2,156,766. The business has a fifty day moving average price of $71.07 and a 200 day moving average price of $71.09. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market cap of $8.00 billion, a P/E ratio of 21.27, a P/E/G ratio of 2.17 and a beta of 0.81. The company has a current ratio of 1.41, a quick ratio of 0.75 and a debt-to-equity ratio of 0.51.

Institutional Trading of Henry Schein

Hedge funds have recently added to or reduced their stakes in the business. Westwood Holdings Group Inc. acquired a new position in shares of Henry Schein during the second quarter valued at $20,631,000. Cetera Investment Advisers grew its position in Henry Schein by 12.9% in the 2nd quarter. Cetera Investment Advisers now owns 5,561 shares of the company's stock valued at $406,000 after buying an additional 637 shares in the last quarter. Creative Planning grew its position in Henry Schein by 12.3% in the 2nd quarter. Creative Planning now owns 16,137 shares of the company's stock valued at $1,179,000 after buying an additional 1,769 shares in the last quarter. SG Americas Securities LLC increased its stake in Henry Schein by 4.2% during the 2nd quarter. SG Americas Securities LLC now owns 327,911 shares of the company's stock valued at $23,954,000 after buying an additional 13,245 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in shares of Henry Schein by 4.7% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 29,853 shares of the company's stock worth $2,181,000 after buying an additional 1,340 shares in the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines